Edgewood Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,000
| Closed | -$829K | – | 84 |
|
|
2023
Q1 | $829K | Hold |
23,000
| – | – | ﹤0.01% | 58 |
|
|
2022
Q4 | $909K | Hold |
23,000
| – | – | ﹤0.01% | 53 |
|
|
2022
Q3 | $924K | Hold |
23,000
| – | – | ﹤0.01% | 50 |
|
|
2022
Q2 | $967K | Hold |
23,000
| – | – | ﹤0.01% | 51 |
|
|
2022
Q1 | $896K | Hold |
23,000
| – | – | ﹤0.01% | 53 |
|
|
2021
Q4 | $917K | Hold |
23,000
| – | – | ﹤0.01% | 56 |
|
|
2021
Q3 | $831K | Sell |
23,000
-20,000
| -47% | -$723K | ﹤0.01% | 57 |
|
|
2021
Q2 | $1.76M | Sell |
43,000
-53,500
| -55% | -$2.19M | ﹤0.01% | 42 |
|
|
2021
Q1 | $4.21M | Hold |
96,500
| – | – | 0.01% | 36 |
|
|
2020
Q4 | $4.83M | Buy |
96,500
+6,500
| +7% | +$325K | 0.01% | 34 |
|
|
2020
Q3 | $3.79M | Buy |
90,000
+20,000
| +29% | +$841K | 0.01% | 39 |
|
|
2020
Q2 | $3.4M | Buy |
+70,000
| New | +$3.4M | 0.01% | 38 |
|